Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients

Launched by RENMIN HOSPITAL OF WUHAN UNIVERSITY · Jun 7, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how an automatic reminder system can help patients who have had polyps removed from their colon (a procedure called postpolypectomy) keep up with their follow-up care. The goal is to see if using phone calls and messages to remind patients about their check-ups improves the rate of surveillance, which is the regular monitoring of their health after the procedure. Patients in the study will be divided into four groups: one group will receive reminders through both calls and messages, another group will only get messages, a third group will have manual reminders, and the last group will not receive any reminders.

To be eligible for this trial, participants need to be at least 18 years old and have undergone a colonoscopy, which is a test used to look at the inside of the colon. However, certain people may not qualify, such as those without a clear test result or with specific health issues. The trial is not yet recruiting participants, so there's no need to sign up just yet. If you or a loved one are interested, keep an eye out for when the study begins, as it may help improve follow-up care for people who have had colon polyps removed.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female aged 18 years or older who undergo colonoscopy.
• Exclusion Criteria:
• • 1)No pathological result.
• • 2) No or invalid contact information.
• • 3) The surveillance interval cannot be determined according to the surveillance guidelines, including poor bowel preparation, colorectal cancer or suspicious malignance, surgery or colorectal ESD history, those who fail to complete colonoscopy due to unbearable, pathological indications of not polyps, hamartoma or lymphoma polyps, history of ulcerative colitis, and so on.
• • 4) Has participated in other clinical trials, signed the informed consent form and is in the surveillance period of other clinical trials.
• • 5) Have drug or alcohol abuse or psychological disorder in the past five years.
• • 6）Pregnancy.
• • 7）Not suitable for recruitment after investigator evaluation because of other high-risk conditions.